Opportunities for disease state management in prostate cancer

Disease Management

Volumn 8, Issue 4, 2005, Pages 235-244

  Pickard, A Simon ^a   Hung, Shih Ying ^a   McKoy, June M ^b   Witt, Whitney P ^b   Arseven, Adnan ^b   Sharifi, Roohollah ^c   Wu, Zhigang ^c   Knight, Sara J ^d   McWilliams, Norene ^b   Schumock, Glen T ^a   Bennett, Charles L ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER HORMONE THERAPY; CANCER SCREENING; CAREGIVER; DIGITAL RECTAL EXAMINATION; HEALTH INSURANCE; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT SATISFACTION; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; SHARED DECISION MAKING; SOCIAL SUPPORT;

DELIVERY OF HEALTH CARE; DISEASE MANAGEMENT; HUMANS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; PROFESSIONAL-FAMILY RELATIONS; PROFESSIONAL-PATIENT RELATIONS; PROGRAM DEVELOPMENT; PROSTATIC NEOPLASMS; SOCIAL SUPPORT;

EID: 24944573694     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2005.8.235     Document Type: Article

References (39)

1. Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832-837.
2. Lynne D. Diabetes disease management in managed care organizations. Dis Manag 2004;7:47-60.
3. Patel PH, Welsh C, Foggs MB. Improved asthma outcomes using a coordinated care approach in a large medical group. Dis Manag 2004;7:102-111.
4. American Cancer Society. ACS cancer facts and figures. Available at: 〈http://www.cancer.org/downloads/STT/CAFF_finalPWSecured.pdf〉.
5. Scherr D, Swindle PW, Scardino PT. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology 2003;61:14-24.
6. Wilt TJ, Partin MR. Reducing PSAnxiety: the importance of noninvasive chronic disease management in prostate cancer detection and treatment. Am J Med 2004;117:796-798.
7. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517-523.
8. D'Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 2004;351:125-135.
9. Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000;283:354-360.
10. Kim-Sing C, Pickles T. Intervention after PSA failure: examination of intervention time and subsequent outcomes from a prospective patient database. Int J Radiat Oncol Biol Phys 2004;60:463-469.
11. Trachtenberg J. Innovative approaches to the hormonal treatment of advanced prostate cancer. Eur Urol 1997;32:78-80.
12. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 2003;8:474-487.
13. Beer TM, Bubalo JS. Prevention and management of prostate cancer chemotherapy complications. Urol Clin North Am 2004;31:367-378.
14. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997;79: 1977-1986.
15. Turini M, Redaelli A, Gramegna P, Radice D. Quality of life and economic considerations in the management of prostate cancer. Pharmacoeconomics 2003;21: 527-541.
16. Echlin KN, Rees CE. Information needs and information-seeking behaviors of men with prostate cancer and their partners: a review of the literature. Cancer Nurs 2002;25:35-41.
17. Srirangam SJ, Pearson E, Grose C, Brown SC, Collins GN, O'Reilly PH. Partner's influence on patient preference for treatment in early prostate cancer. BJU Int 2003;92:365-369.
18. Patel HR, Mirsadraee S, Emberton M. The patient's dilemma: prostate cancer treatment choices. J Urol 2003;169:828-833.
19. Harden J, Schafenacker A, Northouse L, et al. Couples' experiences with prostate cancer: focus group research. Oncol Nurs Forum 2002;29:701-709.
20. George LK, Gwyther LP. Caregiver well-being: a multidimensional examination of family caregivers of demented adults. Gerontologist 1986;26:253-259.
21. Kahn KL, Malin JL, Adams J, Ganz PA. Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure? Med Care 2002;40:III73-III85.
22. Tan EJ, Lui LY, Eng C, Jha AK, Covinsky KE. Differences in mortality of black and white patients enrolled in the program of all-inclusive care for the elderly. J Am Geriatr Soc 2003;51:246-251.
23. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33: 337-343.
24. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
26. Lintz K, Moynihan C, Steginga S, et al. Prostate cancer patients' support and psychological care needs: survey from a non-surgical oncology clinic. Psychooncology 2003;12:769-783.
27. Ware JE Jr, Snyder MK, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Program Plann 1983;6:247-263.
28. Ware JE Jr, Hays RD. Methods for measuring patient satisfaction with specific medical encounters. Med Care 1988;26:393-402.
29. Atkinson MJ, Sinha A, Mass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12.
30. Robinson BC. Validation of a Caregiver Strain Index. J Gerontol 1983;38:344-348.
31. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24: 385-396.
32. Given CW, Given B, Stommel M, Collins C, King S, Franklin S. The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health 1992;15:271-283.
33. Johns Hopkins, American Healthways. Defining the patient-physician relationship for the 21st century. Dis Management 2004;7:161-179.
34. Eton DT, Lepore SJ, Helgeson VS. Early quality of life in patients with localized prostate carcinoma: an examination of treatment-related, demographic, and psychosocial factors. Cancer 2001;92:1451-1459.
35. Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol 2003;22:443-452.
36. National Center for Chronic Disease Prevention and Health Promotion. Chronic Disease Overview. Available at: 〈http://www.cdc.gov/nccdphp/ overview.htm〉.
37. Disease Management Association of America. Definition of Disease Management. Available at: 〈http:// www.dmaa.org/definition.html〉.
38. Gurnee MC, Da Silva RV. Constructing disease management programs. Manag Care 1997;6:67-70,75-76.
39. Berg GD, Wadhwa S, Johnson AE. A matched-cohort study of health services utilization and financial outcomes for a heart failure disease-management program in elderly patients. J Am Geriatr Soc 2004;52: 1655-1661.